An observational study in Musculoskeletal Diseases, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Riphah International University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The primary objective of this study is to translate the Nordic Musculoskeletal (E-NMQ) Questionnaire Modified Version into Urdu following international guidelines. Presently, there exists no validated tool to comprehensively measure symptoms such as pain, stiffness and weakness in Urdu-speaking patients in Pakistan. Specifically, the widely used E-NMQ, having these three vital categories, has yet to be translated and validated for Urdu-speaking individuals with musculoskeletal disease (MSD).
To find the reliability and validity of the Urdu version of E-NMQ in patients of MSD, procedure involves following stages: E-NMQ will be adapted in Urdu and then back translated in English, then will be first tested for its content validity by using the content validity index. Then Urdu version of the E-NMQ will be pilot run; tested for its validity and reliability. In next step Urdu version of the E-NMQ will be tested for its validity and reliability in patients with MSD.
752 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.
This study's planned enrollment of 110 is close to the median of 120 across 207 observational studies indexed under Musculoskeletal Diseases.
Browse Musculoskeletal Diseases studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
ndividuals with a condition affecting the musculoskeletal system
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age between 18 and 45 years.
Exclusion Criteria:
Pregnant females, inflammation, local infection, fracture, suspected tumor, Recent surgery
Urdu version of Nordic Musculoskeletal Questionnaire (E-NMQ) for Urdu-Speaking Populations
Urdu version of Nordic Musculoskeletal Questionnaire (E-NMQ) for Urdu-Speaking Populations
Time frame: 6 weeks
Modified Oswestry Disability Index
As a comparator
Time frame: 6 weeks
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Oct 2026, 2 months after the start.
Of 86 non-industry observational studies under Musculoskeletal Diseases, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 60. This study's planned 2 months is below that.
Counting every sponsor, half of 107 studies reached it within 27 months; a quarter within 7 and three quarters within 74.
Musculoskeletal Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →